What are the common causes of prostatic enlargement in adolescent males with no sexual history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prostatic Enlargement in Adolescents with No Sexual History

Prostatic enlargement in adolescents is exceedingly rare, and when it occurs, the most common cause is idiopathic benign prostatic hyperplasia (BPH), though congenital anomalies such as enlarged prostatic utricles must also be considered in the differential diagnosis.

Epidemiology and Rarity

  • BPH in adolescents is extraordinarily uncommon, with fewer than five cases reported in patients under 18 years of age in the medical literature 1
  • The youngest documented case of juvenile BPH occurred in a 10-year-old boy who presented with hematuria and voiding symptoms 2
  • A 17-year-old case presented with acute urinary retention due to a 48 × 55 × 68 mm prostatic mass, initially suspected to be malignant 1
  • One of the largest juvenile cases reported involved a 20-year-old male with a 380-gram prostate 3

Primary Causes in Adolescents

Idiopathic Benign Prostatic Hyperplasia

  • Most cases of adolescent prostatic enlargement are idiopathic BPH with no identifiable etiologic factor 1
  • The pathophysiology mirrors adult BPH: proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostatic transition zone 4
  • Unlike adult BPH where age and hormonal factors are well-established risk factors 5, the mechanism in adolescents remains unclear 1

Hormonal/Iatrogenic Factors

  • Gonadotropin supplement therapy for undescended testes has been implicated in some juvenile cases 1
  • Maternal use of human chorionic gonadotropin (hCG)-containing agents during pregnancy to prevent spontaneous abortion has been associated with juvenile BPH 1
  • Exogenous androgen exposure should be investigated in the history 4

Congenital Anomalies

  • Enlarged prostatic utricles and vagina masculinus occur in 64.7% of boys with disorders of sex development (DSD) and severe hypospadias 6
  • These cystic dilations posterior to the urethra can mimic prostatic enlargement on imaging 6
  • 80% of patients with severe (Ikoma Grade III) enlarged prostatic utricles have scrotal or perineal meatus 6
  • This diagnosis is particularly relevant in patients with ambiguous genitalia or known DSD 6

Critical Diagnostic Considerations

Malignancy Exclusion

  • Rhabdomyosarcoma is the primary malignant differential that must be excluded in adolescents presenting with prostatic masses 1
  • Transrectal ultrasound-guided biopsy (TRUS-Bx) is essential to document benign tissue and exclude malignancy 1
  • MRI imaging should assess for lymphadenopathy and metastatic disease 1

Clinical Presentation

  • Acute urinary retention is the most common presenting symptom 1, 2
  • Hematuria may be present 1, 2
  • Obstructive voiding symptoms including dysuria, weak stream, and sense of residual urine 3
  • Severe cases can progress to bilateral hydroureteronephrosis and renal insufficiency 2

Diagnostic Workup

  • Digital rectal examination reveals enlarged prostate 1, 3
  • Pelvic ultrasound and MRI demonstrate prostatic mass, often protruding into bladder lumen 1, 2
  • Serum creatinine to assess renal function 2
  • Voiding cystourethrography is mandatory in patients with DSD or severe hypospadias to identify enlarged prostatic utricles 6
  • Endocrinologic evaluation to exclude hormonal abnormalities 1

Management Approach

  • Endoscopic transurethral resection of the prostate (TUR-P) is the treatment of choice for symptomatic juvenile BPH 1
  • Suprapubic prostatectomy may be required for very large glands (>50-55 grams) 3, 2
  • Treatment principles are extrapolated from adult BPH management due to lack of pediatric-specific data 1

Common Pitfalls

  • Assuming all prostatic enlargement in adolescents is malignant: While malignancy must be excluded, documented cases show benign histology is possible 1
  • Missing congenital anomalies: Failing to perform voiding cystourethrography in patients with genital abnormalities can miss enlarged prostatic utricles that require different management 6
  • Overlooking iatrogenic causes: Not obtaining detailed maternal pregnancy history or patient medication history may miss hormonal exposures 1

References

1
Research

Benign prostatic hyperplasia: Case report of a 17-year-old.

Journal of pediatric urology, 2016

4
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Guideline

Risk Factors for Benign Prostatic Hyperplasia (BPH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the common causes of prostatic enlargement in an adolescent male with no sexual history?
What is the best course of treatment for a 71-year-old male with Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) who is currently taking tamsulosin (flomax) 0.4mg twice daily, presenting with weak urinary stream, intermittent urinary incontinence, urgency, and nocturia, and has multiple comorbidities including type 2 diabetes, Coronary Artery Disease (CAD), Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), hypertension, and Chronic Kidney Disease (CKD) stage 2?
What is the risk of complications from Benign Prostatic Hyperplasia (BPH) in a 62-year-old male patient with a Body Mass Index (BMI) of 41?
What are the treatment guidelines for a 68-year-old male patient with benign prostatic hyperplasia (BPH), an enlarged prostate (68.9 grams) with a median lobe projection of 2.56 cm, and elevated prostate-specific antigen (PSA) levels (4.67 ng/mL)?
What is the risk factor for Benign Prostatic Hyperplasia (BPH) in a 62-year-old male with a Body Mass Index (BMI) of 41, classified as obesity?
What is the current treatment recommendation for a patient with fever of unknown origin, stage IV renal cell carcinoma with bone, lung, and liver metastasis, anemia, AKI on top of CKD due to HPNSS, hypertension, BPH, intercritical gout, and a history of right nephrectomy, currently on meropenem?
What is the preferred vasopressor, norepinephrine or phenylephrine, in a patient with coronary artery disease (CAD) and hypotension?
What is the initial management strategy for a patient with chronic stable angina in the outpatient department (OPD), including recommended drug dosages?
What is the recommended treatment for a patient with suspected Dengue?
What is the best course of treatment for a patient with stage IV renal cell carcinoma, impaired renal function, and existing medications pembrolizumab and lenvatinib?
Is there evidence to support a metal allergy in patients with a history of hip replacement or hardware implantation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question